Anavex Life Sciences
AVXL
49 hedge funds and large institutions have $10.5M invested in Anavex Life Sciences in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 48 → 49 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
3.66% less ownership
Funds ownership: 18.08% → 14.42% (-3.7%)
53% less capital invested
Capital invested by funds: $22.3M → $10.5M (-$11.8M)
88% less call options, than puts
Call options by funds: $75K | Put options by funds: $646K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hikari Power
Tokyo,
Japan
|
+$336K |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$121K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$71.3K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$64K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$54.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.31M |
| 2 |
Millennium Management
New York
|
-$1.06M |
| 3 |
Goldman Sachs
New York
|
-$317K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$191K |
| 5 |
ECM
Element Capital Management
New York
|
-$183K |
AVXL Hedge Fund Activity: Q4 2018 in Review
49 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2018, worth a combined $10.5M — down 53% from $22.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AVXL positions and 7 closed out — a net gain of 1 holder — while 12 added to existing stakes and 12 trimmed.
The largest buyer was Hikari Power, opening a new position worth an estimated $336K. The largest seller was Vanguard Group, cutting an estimated $2.31M.
- 49 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2018, up from 48 in Q3 2018.
- Funds reported $10.5M of Anavex Life Sciences stock for Q4 2018, down 53% quarter-over-quarter.
- 8 funds opened new Anavex Life Sciences positions in Q4 2018 and 7 closed out, a net change of +1 holder.
- The largest Anavex Life Sciences buyer in Q4 2018 was Hikari Power, an estimated $336K added.
- The largest Anavex Life Sciences seller in Q4 2018 was Vanguard Group, an estimated $2.31M sold.
Based on aggregated 13F filings for Q4 2018.